Last reviewed · How we verify
NCT04046601
Impedance Spectroscopy in Esophageal Cancer
NA trial testing impedance in Cancer of Esophagus in 67 participants. Completed in 15 February 2020.
1 February 2020
Quick facts
| Lead sponsor | Sana Klinikum Offenbach |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 67 |
| Start date | 9 October 2019 |
| Primary completion | 1 February 2020 |
| Estimated completion | 15 February 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- impedance
Conditions studied
- Cancer of Esophagus — all drugs for Cancer of Esophagus →
Sponsor
Sana Klinikum Offenbach
Who can join
Adults 18 to 99, any sex, with Cancer of Esophagus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Detection of early esophageal cancer in surrounding normal tissue can be challenging even for experienced examiners. The early detection is essential to determine the following treatment. Early stages of esophageal cancers can be treated by endoscopic resection whereas advanced neoplasia might lead to an Operation of the esophagus. Diagnosis is made usually by biopsies of suspicious lesions or untargeted quadrant biopsies. The electrical properties in inflammatory tissue and cancer can be sensed by electrical bioimpedance technique. The aim of this study is to compare the impedance probe with the histological result and to investigate the feasibility of the new technique in detection of esophageal cancer.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Virtual Biopsy by Electrical Impedance Spectroscopy in Barrett's Carcinoma.
Blößer S, May A, Welsch L, Ast M, et al · · 2022 · cited 3× · PMID 34559362 · DOI 10.1007/s12029-021-00703-0
Verify or expand the search:
- PubMed search for NCT04046601
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer of Esophagus
Currently open trials in the same condition.
- NCT04258813 — Onco-primary Care Networking to Support TEAM-based Care · NA · active not recruiting
- NCT04886635 — Surgery As Needed for Oesophageal Cancer - 2 · recruiting
- NCT04455282 — CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1 · recruiting
- NCT05179824 — Tempus Priority Study: A Pan-tumor Observational Study · active not recruiting
- NCT03347162 — Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer · active not recruiting
Other Sana Klinikum Offenbach trials
Trials by the same sponsor.
- NCT07535697 — Ultrasound-Guided Erector Spinae Plane Block Versus Thoracoscopically-Guided Intercostal Nerve Block in Video-Assisted T · NA · not yet recruiting
- NCT06394479 — Long-term Results After Bariatric Surgery in Type 1 Diabetes Patients · completed
- NCT03045679 — One-anastomosis Gastric Bypass/Mini-Gastric Bypass Versus Roux-en Y Gastric Bypass · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04046601 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sana Klinikum Offenbach
- Last refreshed: 17 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04046601.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing